Clinical/ News/ R&D Novartis on track to bring first CAR-T to market Andrew McConaghie CAR T, LentiGlobin BB305, Novartis 0 Comment Novartis says its chimeric antigen receptors (CAR-T) candidate is on track for filing in 2017, which could make Share X Novartis on track to bring first CAR-T to market https://pharmaphorum.com/news/novartis-on-track-to-be-first-car-t-to-market/
